Evolution of GAPDH as a druggable target of tumor glycolysis??

摘要

Deregulation of energy metabolism, also known as the metabolic reprogramming is a frequently witnessed biochemical phenotype of many solid malignancies, and has recently been recognized as one of the hallmarks of cancer